27 January 2017 in Polymer Chemistry
Safe and efficient drug delivery systems have received great attention for cancer therapy due to their enhanced cancer-targeting efficiency and reduced undesirable side effects. Administration, safety, and effectiveness are the main issues for clinical trials in nanomedicine. Here, we develop a series of poly(lactic-co-glycolic acid)-co-polyspermine (PLGA-PSPE) copolymers via a simple polymerization reaction between activated carboxyl groups of poly(lactic-co-glycolic acid) (PLGA) and amine groups of polyspermine (PSPE) with different molecular weights (Mw) for safe and efficient lung cancer drug delivery. PLGA-PSPE can self-assemble into polymeric micelles with a low critical micelle concentration. PLGA-PSPE had very low cytotoxicity and hemolytic activity. In addition, PLGA-PSPE also had no potential systemic toxicity after aerosol delivery to mice. Dihydroergotamine tartrate (DHE), which could suppress lung cancer cell survival by induction of apoptosis and mitophagy in the latest study, was employed as the model hydrophobic drug and encapsulated into PLGA-PSPE polymeric micelles (PLGA-PSPE/DHE). PLGA-PSPE/DHE could be stored at 25 °C for 7 days, and showed a controlled and sustained drug release, and time and dose dependent cellular uptake. Moreover, PLGA-PSPE/DHE efficiently increased apoptosis and mitophagy in A549 lung cancer cells. Furthermore, PLGA-PSPE/DHE significantly reduced tumor sizes and numbers, and efficiently suppressed lung tumorigenesis in K-rasLA1 lung cancer model mice after aerosol delivery. These results indicate that PLGA-PSPE polymeric micelles have a potential as an anticancer drug delivery carrier for lung cancer therapy.
28 January 2019 in Cancer Science
Metformin, a drug for type 2 diabetes mellitus, has shown therapeutic effects for various cancers. However, it had no beneficial effects on the survival rate of human malignant mesothelioma (HMM) patients. The present study was performed to elucidate the underlying mechanism of metformin resistance in HMM cells. Glucose‐starved HMM cells had enhanced resistance to metformin, demonstrated by decreased apoptosis and autophagy and increased cell survival. These cells showed abnormalities in mitochondria, such as decreased ATP synthesis, morphological elongation, altered mitochondrial permeability transition pore and hyperpolarization of mitochondrial membrane potential (MMP). Intriguingly, Mdr1 was significantly upregulated in mitochondria but not in cell membrane. The upregulated mitochondrial Mdr1 was reversed by treatment with carbonyl cyanide m‐chlorophenyl hydrazone, an MMP depolarization inducer. Furthermore, apoptosis and autophagy were increased in multidrug resistance protein 1 knockout HMM cells cultured under glucose starvation with metformin treatment. The data suggest that mitochondrial Mdr1 plays a critical role in the chemoresistance to metformin in HMM cells, which could be a potential target for improving its therapeutic efficacy.
18 May 2021 in Molecular Carcinogenesis
1 January 2021 in Journal of Veterinary Science
Ji S, et al. J Vet Sci. 2021 Jan;22(1):e14. https://doi.org/10.4142/jvs.2021.22.e14
31 December 2021 in Korean Journal of Veterinary Research
An 11-year-old obese dog was referred for a liver mass. Cytologic examination revealed vacuolated hepatocytes with mild pleomorphism. A partial liver lobectomy was performed. On histopathologic examination, the mass was diagnosed as hepatocellular carcinoma composed of hepatocytes with clear vacuoles. These findings were consistent with clear cell hepatocellular carcinoma (CCHCC). The CCHCC is a rare subtype of hepatocellular carcinoma in dogs, and clinical features are poorly defined. This is the first report on the cytological, histological and clinical aspects of CCHCC, suggesting that obesity and hyperlipidemia are potential risk factors for CCHCC in dogs.
2 October 2025 in Gastric Cancer